Cochrane Reviews on COVID-19 by the READ-It team

Cochrane Reviews: COVID-19

0

New review: The effect of sample site and collection procedure on identification of SARS‐CoV‐2 infection

The review authors compared the sensitivity of different sampling collection sites and methods for the detection of current SARS‐CoV‐2 infection with any molecular or antigen‐based test.

Cochrane Systematic Review: NEW

Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID‐19 in people with SARS‐CoV‐2

The authors of this review assessed the accuracy of routine blood‐based laboratory tests to predict mortality and deterioration to severe or critical (from mild or moderate) COVID‐19 in people with SARS‐CoV‐2.

Cochrane Systematic Review: NEW

Favipiravir for treating COVID‐19

The authors of this new review assessed the effects of favipiravir compared to no treatment, supportive treatment, or other experimental antiviral treatment in people with acute COVID‐19.

Cochrane Systematic Review: NEW

Update: Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

The combination of nirmatrelvir with ritonavir (Paxlovid®) is a new medicine developed to treat infection with the SARS‐CoV‐2 virus and aims to avoid severe COVID‐19 in people without symptoms, or those with mild symptoms. This review update assesses the efficacy and safety of nirmatrelvir/ritonavir plus standard of care (SoC) compared to SoC with or without placebo, or any other intervention for treating COVID-19 or preventing SARS-CoV-2 infection.

Cochrane Systematic Review: UPDATE